Grissinger Michael — SEC Form 4 filings

SEC reporting owner CIK 1757601. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-06-21 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aprea Therapeutics, Inc. (APRE)Director36
Adicet Bio, Inc. (ACET)Director22
Akari Therapeutics Plc (AKTX)Director11
Lipocine Inc. (LPCN)Director11

Form 4 filings — Grissinger Michael

FiledFormIssuerReported transactionsSource
2026-08-074Lipocine Inc. (LPCN)Grant/award (A): 2,000 (derivative) @ $2.11EDGAR
2026-06-234Adicet Bio, Inc. (ACET)Grant/award (A): 4,200 (derivative) @ $0EDGAR
2026-06-174Aprea Therapeutics, Inc. (APRE)Grant/award (A): 3,135 @ $0 · Grant/award (A): 12,555 (derivative) @ $0EDGAR
2025-06-094Aprea Therapeutics, Inc. (APRE)Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0EDGAR
2025-04-214Adicet Bio, Inc. (ACET)Grant/award (A): 70,200 (derivative) @ $0EDGAR
2024-07-024Akari Therapeutics Plc (AKTX)Grant/award (A): 5,000,000 (derivative) @ $0EDGAR
2024-06-214Aprea Therapeutics, Inc. (APRE)Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1757601 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →